$CCRD
CoreCard Corp Stock $ccrd

$ccrd Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000143774924024185 Filed on August 01, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$15.70M	$13.80M
YoY Change	17.2%	-12.08%
Cost Of Revenue	$8.999M	$9.090M
YoY Change	-3.02%	-0.21%
Gross Profit	$6.704M	$4.707M
YoY Change	62.72%	-28.5%
Gross Profit Margin	42.69%	34.12%
Selling, General & Admin	$1.418M	$1.606M
YoY Change	16.42%	-11.17%
% of Gross Profit	21.15%	34.12%
Research & Development	$2.501M	$1.952M
YoY Change	0.48%	-6.69%
% of Gross Profit	37.31%	41.47%
Depreciation & Amortization	$849.0K	$902.0K
YoY Change	-37.11%	-53.98%
% of Gross Profit	12.66%	19.16%
Operating Expenses	$3.919M	$3.558M
YoY Change	5.72%	-8.77%
Operating Profit	$2.785M	$1.149M
YoY Change	574.33%	-57.17%
Interest Expense	-$90.00K	-$199.0K
YoY Change	350.0%	-49.1%
% of Operating Profit	-3.23%	-17.32%
Other Income/Expense, Net	$233.0K	$235.0K
YoY Change	-24.35%	16.92%
Pretax Income	$2.928M	$1.185M
YoY Change	-1095.92%	-52.47%
Income Tax	$732.0K	$289.0K
% Of Pretax Income	25.0%	24.39%
Net Earnings	$2.196M	$896.0K
YoY Change	-1089.19%	-52.21%
Net Earnings / Revenue	13.98%	6.49%
Basic Earnings Per Share	$0.28	$0.11
Diluted Earnings Per Share	$0.27	$0.11
COMMON SHARES
Basic Shares Outstanding	8.025M	8.161M
Diluted Shares Outstanding	8.018M	8.143M

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$28.01M	$27.85M
YoY Change	-23.81%	-22.87%
Cash & Equivalents	$22.50M	$22.59M
Short-Term Investments	$5.511M	$5.257M
Other Short-Term Assets	$6.522M	$5.738M
YoY Change	10.79%	47.73%
Inventory
Prepaid Expenses
Receivables	$7.320M	$7.097M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$41.85M	$40.68M
YoY Change	-13.75%	-11.75%
LONG-TERM ASSETS
Property, Plant & Equipment	$11.95M	$11.84M
YoY Change	2.34%	-20.97%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$3.378M	$3.624M
YoY Change	-2.9%	-19.36%
Other Assets	$5.371M	$5.411M
YoY Change	82.25%	1294.59%
Total Long-Term Assets	$20.96M	$20.88M
YoY Change	14.76%	5.09%
TOTAL ASSETS
Total Short-Term Assets	$41.85M	$40.68M
Total Long-Term Assets	$20.96M	$20.88M
Total Assets	$62.81M	$61.56M
YoY Change	-5.95%	-6.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.628M	$1.154M
YoY Change	-4.68%	-17.98%
Accrued Expenses	$1.050M	$991.0K
YoY Change	30.27%	-65.59%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$8.544M	$8.007M
YoY Change	-16.57%	0.46%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$372.0K	$313.0K
YoY Change	-78.5%	-83.69%
Total Long-Term Liabilities	$2.577M	$2.701M
YoY Change	13.57%	40.75%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.544M	$8.007M
Total Long-Term Liabilities	$2.577M	$2.701M
Total Liabilities	$11.12M	$10.71M
YoY Change	-11.1%	3.13%
SHAREHOLDERS EQUITY
Retained Earnings	$59.84M	$57.65M
YoY Change	7.18%	2.84%
Common Stock	$17.57M	$17.30M
YoY Change	5.14%	3.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$51.69M	$50.85M
YoY Change
Total Liabilities & Shareholders Equity	$62.81M	$61.56M
YoY Change	-5.95%	-6.68%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	$2.196M	$896.0K
YoY Change	-1089.19%	-52.21%
Depreciation, Depletion And Amortization	$849.0K	$902.0K
YoY Change	-37.11%	-53.98%
Cash From Operating Activities	$2.698M	$1.789M
YoY Change	-13.8%	-85.3%
INVESTING ACTIVITIES
Capital Expenditures	$980.0K	$1.160M
YoY Change	16.67%	-51.36%
Acquisitions
YoY Change
Other Investing Activities	-$83.00K	$22.00K
YoY Change	-86.39%	-152.38%
Cash From Investing Activities	-$1.063M	-$1.138M
YoY Change	-26.69%	-53.11%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.711M	-2.070M
YoY Change	56.97%	371.53%
NET CHANGE
Cash From Operating Activities	2.698M	1.789M
Cash From Investing Activities	-1.063M	-1.138M
Cash From Financing Activities	-1.711M	-2.070M
Net Change In Cash	-76.00K	-1.419M
YoY Change	-112.88%	-115.25%
FREE CASH FLOW
Cash From Operating Activities	$2.698M	$1.789M
Capital Expenditures	$980.0K	$1.160M
Free Cash Flow	$1.718M	$629.0K
YoY Change	-24.98%	-93.57%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2493000	usd
CY2024Q2	us-gaap	Investment Income Net InvestmentIncomeNet	-199000	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	235000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	201000	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	289000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	618000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	896000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	1875000	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.11
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.11
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8084335
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8143247
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1557000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7536000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	4805000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	44489000	usd
CY2023Q4	us-gaap	Long Term Investments LongTermInvestments	4062000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11319000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3956000	usd
CY2023Q4	us-gaap	Assets Assets	63826000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2172000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	971000	usd
CY2024Q2	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	205000	usd
CY2023Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	265000	usd
CY2024Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2701000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1582000	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.22
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.16
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.22
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.16
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8493040
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8516573
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8207004
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	1875000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-48000	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	865000	usd
CY2023Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1869000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1298000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	52763000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1121000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	15692000	usd
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Central Index Key EntityCentralIndexKey	0000320340
	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2024Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
	ccrd	Otherthantemporary Impairment Loss Debt Securities Availablefor Sale1 OtherthantemporaryImpairmentLossDebtSecuritiesAvailableforSale1	0	usd
CY2024Q2	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	6	pure
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	0
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2024Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	0	usd
CY2024Q2	ccrd	Number Of Stockbased Compensation Plans In Effect NumberOfStockbasedCompensationPlansInEffect	2	pure
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22589000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	26918000	usd
CY2024Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	5257000	usd
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	5230000	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7097000	usd
CY2024Q2	us-gaap	Other Assets Current OtherAssetsCurrent	5738000	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	40681000	usd
CY2024Q2	us-gaap	Long Term Investments LongTermInvestments	3624000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11841000	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5411000	usd
CY2024Q2	us-gaap	Assets Assets	61557000	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1154000	usd
CY2024Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1572000	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2310000	usd
CY2024Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2150000	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	991000	usd
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2140000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2530000	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	8007000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	9540000	usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2183000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9026940
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9016140
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8024518
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8295408
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	91000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	90000	usd
CY2024Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	17205000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	16621000	usd
CY2024Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	1002422
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	720732
CY2024Q2	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	24097000	usd
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	20359000	usd
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	4000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	32000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	57646000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	56320000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	50849000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	52704000	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	61557000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	63826000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	13797000	usd
CY2024Q2	us-gaap	Cost Of Revenue CostOfRevenue	9090000	usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue	9296000	usd
CY2024Q2	us-gaap	Marketing Expense MarketingExpense	116000	usd
CY2023Q2	us-gaap	Marketing Expense MarketingExpense	105000	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1490000	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1516000	usd
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1952000	usd
CY2023Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2092000	usd
CY2023Q2	us-gaap	Investment Income Net InvestmentIncomeNet	-391000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1185000	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8160235
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	896000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	17000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-12000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	6000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-50000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	1256000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	37000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-53000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	54003000	usd
CY2023Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	443000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	1875000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	150000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-12000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	6000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	55579000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	52704000	usd
CY2024Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	1647000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	430000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	160000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	5000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-2000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	51650000	usd
CY2024Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	2091000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	896000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	425000	usd
	us-gaap	Net Income Loss NetIncomeLoss	1326000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1927000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3655000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	585000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	150000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-159000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	22000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-438000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-686000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-439000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-7110000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	933000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	449000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-210000	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-362000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-104000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-489000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-22000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	115000	usd
	ccrd	Increase Decrease In Deferred Revenue Current IncreaseDecreaseInDeferredRevenueCurrent	-738000	usd
	ccrd	Increase Decrease In Deferred Revenue Current IncreaseDecreaseInDeferredRevenueCurrent	630000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	20000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	352000	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-588000	usd
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-44000	usd
	ccrd	Increase Decrease In Deferred Revenue Noncurrent IncreaseDecreaseInDeferredRevenueNoncurrent	-60000	usd
	ccrd	Increase Decrease In Deferred Revenue Noncurrent IncreaseDecreaseInDeferredRevenueNoncurrent	-110000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2341000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	15121000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2753000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4013000	usd
	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	100000	usd
	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	110000	usd
	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	200000	usd
	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	-0	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	1089000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	852000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	1023000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	726000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2919000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4029000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3701000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	439000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3701000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-439000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-50000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-47000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-4329000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	10606000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	26918000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	20399000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	22589000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	31005000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1086000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	920000	usd
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	162000	usd
	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	110000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	13797000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	15692000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	26873000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	30448000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	13797000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	15692000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	26873000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	30448000	usd
CY2023Q3	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	650000	usd
CY2023Q3	ccrd	Notes Receivable Stated Interest Rate NotesReceivableStatedInterestRate	0.0525	pure
	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	200000	usd
CY2024Q2	ccrd	Notes Receivable Stated Interest Rate NotesReceivableStatedInterestRate	0.0525	pure
CY2024Q2	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	240000	usd
CY2024Q2	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	455000	usd
CY2024Q2	us-gaap	Equity Method Investments EquityMethodInvestments	3624000	usd
CY2024Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	-199000	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-438000	usd
CY2023Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	-391000	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-686000	usd
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	425000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	150000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	585000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	150000	usd
	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	3.5
	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	39.11
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	59000
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y1M6D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	17.35
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	195250	usd
CY2024Q2	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	22955000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	562000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	586000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	1506000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	1556000	usd
CY2024Q2	ccrd	Debt Securities Availableforsale Amortized Cost Maturity Allocated And Single Maturity Date After Year One Through Three DebtSecuritiesAvailableforsaleAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughThree	4591000	usd
CY2024Q2	ccrd	Debt Securities Availablefor Sale Maturity Allocated And Single Maturity Date Rolling After One Through Three Years Fair Value DebtSecuritiesAvailableforSaleMaturityAllocatedAndSingleMaturityDateRollingAfterOneThroughThreeYearsFairValue	4671000	usd
CY2023Q4	ccrd	Debt Securities Availableforsale Amortized Cost Maturity Allocated And Single Maturity Date After Year One Through Three DebtSecuritiesAvailableforsaleAmortizedCostMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughThree	3607000	usd
CY2023Q4	ccrd	Debt Securities Availablefor Sale Maturity Allocated And Single Maturity Date Rolling After One Through Three Years Fair Value DebtSecuritiesAvailableforSaleMaturityAllocatedAndSingleMaturityDateRollingAfterOneThroughThreeYearsFairValue	3674000	usd
CY2024Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	5153000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	5257000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	5113000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	5230000	usd
CY2024Q2	ccrd	Operating Lease Rightofuse Asset And Lease Liability OperatingLeaseRightofuseAssetAndLeaseLiability	3270000	usd
CY2023Q4	ccrd	Operating Lease Rightofuse Asset And Lease Liability OperatingLeaseRightofuseAssetAndLeaseLiability	2003000	usd
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y6M
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y9M18D
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.062	pure
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.034	pure
	us-gaap	Operating Lease Payments OperatingLeasePayments	659000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	674000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	724000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1109000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1018000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	491000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	405000	usd
CY2024Q2	ccrd	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	102000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3849000	usd
CY2024Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	362000	usd
CY2023Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	343000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	659000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	674000	usd

Files In Submission

Name	View Source	Status
ccrd-20240630_cal.xml	Edgar Link	unprocessable
ccrd-20240630_lab.xml	Edgar Link	unprocessable
0001437749-24-024185-index-headers.html	Edgar Link	pending
0001437749-24-024185-index.html	Edgar Link	pending
0001437749-24-024185.txt	Edgar Link	pending
0001437749-24-024185-xbrl.zip	Edgar Link	pending
ccrd-20240630.xsd	Edgar Link	pending
ex_703491.htm	Edgar Link	pending
ex_703492.htm	Edgar Link	pending
ex_703493.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
ins20240630_10q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
ccrd-20240630_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ins20240630_10q_htm.xml	Edgar Link	completed
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ccrd-20240630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CCRD
CoreCard Corp Stock $ccrd

2024 Q3 Form 10-Q Financial Statement

#000143774924024185 Filed on August 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CCRD CoreCard Corp Stock $ccrd

2024 Q3 Form 10-Q Financial Statement

#000143774924024185 Filed on August 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CCRD
CoreCard Corp Stock $ccrd